等待開盤 11-17 09:30:00 美东时间
-0.430
-6.62%
今日重点评级关注:HC Wainwright & Co.:维持PDS Biotechnology"买入"评级,目标价从13美元升至15美元;HC Wainwright & Co.:维持PepGen Inc."买入"评级,目标价从18美元升至20美元
11-14 10:43
Cantor Fitzgerald analyst Steve Seedhouse downgrades Korro Bio (NASDAQ:KRRO) from Overweight to Neutral.
11-13 21:28
Approximately 34% reduction in workforce impacting all levels of the organization.
11-13 05:51
Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(1.92) per share which beat the analyst consensus estimate of $(2.59) by 25.98 percent. This is a 15.04 percent increase over losses of $(2.26) per share from the
11-13 05:46
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
Clear Street analyst Bill Maughan initiates coverage on Korro Bio (NASDAQ:KRRO) with a Buy rating and announces Price Target of $93.
10-31 17:45
Gainers iBio (NASDAQ:IBIO) stock increased by 28.8% to $1.15 during Monday's a...
10-21 05:08
Korro Bio ( ($KRRO) ) just unveiled an announcement. On October 7, 2025, Vineet...
10-08 19:57
A handful of biotech stocks are showing renewed strength, with big spikes in their Benzinga Edge Ranking's Momentum scores.
09-12 17:27
Gainers Pelthos Therapeutics (AMEX:PTHS) stock increased by 25.9% to $28.27 du...
09-04 01:06